We Haven’t Seen The End Of GMO Labelling Campaign

Jan 25, 2013

Failed California ‘Right to Know’ Campaign Says It Will Be Back In 2014

The California ‘Right to Know’ campaign, which was unsuccessful in its ballot initiative (Prob. 37) for labelling genetically engineered foods in November 2012, says that they will be back in 2014.

The campaign sent out an email to its supporters saying that they believe that their initiative failed because their opponents were able to raise more funds against their campaign, by a margin of 6-to-1.

In addition to outlining their intentions to come back in 2014, the steering committee also said that it will be heavily involved in Washington State’s new GMO proposal, along as having a watchful eye in other state legislative proposals.

Other state legislatures which have similar bills as the failed California initiative include New Mexico and Missouri. It’s also expected that Vermont and Connecticut will have similar bills introduced in the near future.

The California (Prob. 37) vote failed, but managed to secure 48.6% of the vote

Video: Intrauterine Vaccines in Swine - Dr. Heather Wilson

In this episode of The Swine it Podcast Show Canada, Dr. Heather Wilson from VIDO at the University of Saskatchewan explains how intrauterine vaccination is being developed as a new option for swine health. She shares how formulation, adjuvants, and delivery methods influence immune responses and what early trials reveal about safety and reproductive performance. Listen now on all major platforms.

"The idea was that an intrauterine vaccine might avoid a tolerance response and instead create an active immune response."

Meet the guest: Dr. Heather Wilson / heather-wilson-a8043641 is a Senior Scientist and Program Manager at the Vaccine and Infectious Disease Organization at the University of Saskatchewan. Her work centers on vaccine formulation and delivery in pigs, including the development of intrauterine vaccination to support reproductive health and passive protection of piglets. Her background spans biochemistry, immunology, and functional pathogenomics.